# Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT04901455** · EARLY_PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 24 (actual)

## Conditions studied

- COPD

## Interventions

- **BIOLOGICAL:** LAIV

## Key facts

- **NCT ID:** NCT04901455
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-03
- **Primary completion:** 2026-02-16
- **Final completion:** 2026-02-16
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901455, "Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04901455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*